Home NDC 14335-120 daptomycin
Product NDC 14335-120
11-digit product format 143350120
Labeler code 14335
Product ID 14335-120_0a1a4553-120c-b67d-e063-6294a90a0572
Type HUMAN PRESCRIPTION DRUG
Nonproprietary name daptomycin
Dosage form INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION
Route INTRAVENOUS
Labeler Hainan Poly Pharm., Co., Ltd.
Application ANDA215890
Marketing category ANDA
Marketing start 2023-11-14
Substance DAPTOMYCIN
Active strength 500 mg/20mL
Pharmacologic classes Lipopeptide Antibacterial [EPC], Lipopeptides [CS]
NDC exclude flag No
Listing certified through 2026-12-31
Current FDA listing Yes Source provenance: Browse the complete Orange Book source catalog · source snapshot 1 .
Orange Book products# Current product rows page 1 of 1 · 1 matching rows.
Application-product, Trade name, Ingredient table Application-product Trade name Ingredient Strength Dosage form / route TE codes RLD / RS Approval date A215890-001 DAPTOMYCIN DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18
Therapeutic equivalence codes# Current TE-code rows page 1 of 1 · 1 matching rows.
Application-product, TE code table Application-product TE code A215890-001 AP
Observed Orange Book product history# Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
Captured, Edition, Application-product table Captured Edition Application-product Trade name Strength Dosage form / route Product TE source text RLD / RS Approval date Source SHA-256 2026-02-19 14:30 UTC 2026-02 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 011fe1cb6892…2025-12-14 10:44 UTC · 2 captures of this ZIP 2025-12 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 31067a03dcf5…2025-08-23 18:47 UTC 2025-08 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 6a471c1ec25d…2025-03-22 03:13 UTC · 3 captures of this ZIP 2025-03 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 fd3edfee7708…2025-02-26 10:13 UTC · 3 captures of this ZIP 2025-02 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 b8a1b40f171c…2025-01-19 17:59 UTC · 7 captures of this ZIP 2025-01 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 03ed91905a0d…2024-12-13 21:23 UTC · 2 captures of this ZIP 2024-12 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 2680178bc6a6…2024-09-14 05:58 UTC · 2 captures of this ZIP 2024-09 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 5bbf6a4d5a75…2024-11-08 22:44 UTC · 3 captures of this ZIP 2024-11 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 d8e5a09893c0…2024-10-29 15:01 UTC 2024-10 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 d06236e962d9…2024-08-13 05:28 UTC · 3 captures of this ZIP 2024-08 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 79d66fd596c7…2024-07-13 05:37 UTC · 2 captures of this ZIP 2024-07 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 301d65b070ca…2024-06-18 03:08 UTC · 5 captures of this ZIP 2024-06 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 1e350fbaab3a…2024-05-31 18:47 UTC 2024-05 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 8072bd15b7f6…2024-03-16 18:09 UTC · 4 captures of this ZIP 2024-03 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 6a51e52b5d6a…2024-02-18 07:12 UTC 2024-02 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 1c564ffb4f44…2023-12-20 04:57 UTC 2023-12 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 ea1830bbd6c7…2023-11-28 05:40 UTC · 2 captures of this ZIP 2023-11 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 a72a2bbeb626…2023-10-25 00:34 UTC · 2 captures of this ZIP 2023-10 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 9b2671bbb829…2023-07-15 15:27 UTC · 2 captures of this ZIP 2023-07 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS 2022-08-18 a67488948f0b…2023-06-13 01:57 UTC · 3 captures of this ZIP 2023-06 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS 2022-08-18 3f0d92c62455…2023-05-13 08:27 UTC 2023-05 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS 2022-08-18 053a50430f4f…2023-01-26 05:58 UTC 2023-01 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 3bdfa0b2c4d7…2022-11-12 20:34 UTC · 5 captures of this ZIP 2022-11 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 3a93d1ddd44b…2022-10-28 04:53 UTC 2022-10 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 f41ea6bd6efb…2022-09-29 23:25 UTC 2022-09 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 e64feba35796…2026-07-26 02:55 UTC · 3 captures of this ZIP 2026-06 A215890-001 DAPTOMYCIN 500MG/VIAL POWDER / INTRAVENOUS AP 2022-08-18 a50c72e98297…
Observed Orange Book normalized TE history# Additional Listing Data#
Finished product Yes
Brand name base daptomycin
Listing expiration 2026-12-31 Active Ingredients# Ingredient, Strength table Ingredient Strength DAPTOMYCIN 500 mg/20mL
Harmonized UNII identifiers# UNII identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination NWQ5N31VKK Internal UNII lookup
Harmonized RxCUI identifiers# RxCUI identifiers page 1 of 1 · 1 matching rows.
Identifier, FDA.report destination table Identifier FDA.report destination 403920 Internal RxNorm lookup
Harmonized SPL set identifiers# SPL set identifiers page 1 of 1 · 1 matching rows.
DailyMed Product Concepts# DailyMed Package Descriptions# Package NDC, Product, Description table Package NDC Product Description Form Quantity Strength SPL version 14335-120-01 daptomycin 20 mL in 1 VIAL, SINGLE-DOSE INJECTION, POWDER, LYOPHILIZED, 20 1
DailyMed Dashboard NDC Coverage# NDC, Dashboard title, SPL version table NDC Dashboard title SPL version Validation Dashboard ZIP 14335-120 DAPTOMYCIN INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION [HAINAN POLY PHARM., CO., LTD.] 1 Current NDC, 1 package rows 20231115_6ec53f7e-9a5f-4b24-84e9-c94325750e32.zip
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 1 of 1 · 3 matching rows.
DailyMed RxNorm Mappings# Packages# Package NDC, 11-digit format, Description table Package NDC 11-digit format Description Units Marketing start Sample Exclude flag Status 14335-120-01 14335012001 20 mL in 1 VIAL, SINGLE-DOSE (14335-120-01) 20 ml 2023-11-14 No No Current